Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(3)
About
Natco Pharma Ltd.
NSE: NATCOPHARM
|
BSE: 524816
|
ISIN: INE987B01026
|
Industry: Pharmaceuticals
Dividend
High Gain High Volume
|
Mid-range Performer
879.0000
48.85
(
5.88
%)
NSE
Nov 20, 2025
13:42 PM
41.59% Fall from 52W High
Volume:
6.0M
High volume+gain today
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Natco Pharma Ltd.
07 Oct 2024
Dividend
High Gain High Volume
879.00
5.88%
Natco Pharma
Buy:
Natco Pharma Ltd.
by
ICICI Direct
Target: 1675
Target
ICICI Direct
ICICI Securities Limited downgraded Natco Pharma Ltd. to Sell with a price target of 750.0 on 15 Nov, 2025.
More from Natco Pharma Ltd.
Recommended
Market trades higher, Citibank downgrades Biocon to a 'Sell' call from 'Buy'
Trendlyne Marketwatch |
20 Nov 2025, 01:42PM
Inflation Is near zero. So why Is the RBI not cutting rates?
The Baseline |
20 Nov 2025, 01:04PM
Earnings Call Transcript - Q4FY20 for Natco Pharma
|
18 Jun 2020, 06:25PM